Cover Story
Conversation with The Cancer LetterFree
Over the past three years, the American Cancer Society has recovered from the fundraising decline brought on by COVID-19 and has reversed the years-long fundraising slump in public support.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for May 2024
The National Cancer Institute approved the following clinical research studies last month.
CURRENT ISSUE
CURRENT ISSUE
Trending Stories
- Over three years as CEO, Karen Knudsen led ACS through COVID—and reversed the charity’s long slump
- Canine cancers as models: We have barely tapped the full potential of comparative oncology
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Cold Spring Harbor and Northwell extend collaboration with $150M commitment
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community